News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

enGene, Inc. to Present Key Data at Two Diabetes Conferences


10/25/2007 8:57:00 AM

VANCOUVER, BRITISH COLUMBIA--(Marketwire - October 25, 2007) - enGene, Inc., a privately held biotechnology company developing an innovative approach for the long-term treatment of diabetes called GEMS™-Insulin, announced today that two scientific co-founders will be presenting new data on the company's core technology:

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES